Artery Technology Corporation (TPEX:6907)
Taiwan · Delayed Price · Currency is TWD 199.50
+18.00 (9.92%)
At close: Sep 7, 2026
Artery Technology Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| 2,432 | 1,666 | 1,635 | 1,014 | 1,368 | |
Revenue Growth | 43.13% | 1.91% | 61.18% | -25.86% | - |
Cost of Revenue | 1,543 | 1,102 | 1,150 | 776.26 | 771.38 |
Gross Profit | 889.51 | 564.09 | 484.73 | 238.05 | 596.69 |
Selling, General & Admin | 229.98 | 198.64 | 177.88 | 159.31 | 170.79 |
Research & Development | 341.05 | 250.91 | 229.16 | 174.59 | 224.64 |
Operating Expenses | 571.04 | 449.54 | 407.04 | 333.91 | 395.43 |
Operating Income | 318.47 | 114.55 | 77.69 | -95.86 | 201.26 |
Interest Expense | -0.77 | -0.75 | -2.12 | -6.33 | -0.32 |
Interest & Investment Income | 10.93 | 6.21 | 5.54 | 2.31 | 1.87 |
Currency Exchange Gain (Loss) | 7.68 | -5.82 | -9.36 | -1.44 | -5.79 |
Other Non Operating Income (Expenses) | 15.75 | 22.17 | 27.92 | 15.41 | -0.29 |
EBT Excluding Unusual Items | 352.05 | 136.35 | 99.67 | -85.9 | 196.73 |
Gain (Loss) on Sale of Assets | -0 | -0 | - | - | - |
Asset Writedown | - | - | - | 3.8 | -3.8 |
Other Unusual Items | - | 0.01 | 0.1 | 1.04 | 0 |
Pretax Income | 352.05 | 136.36 | 99.77 | -81.07 | 192.93 |
Income Tax Expense | 40.44 | 29.66 | 14.43 | -4.99 | 53.42 |
Net Income | 311.62 | 106.7 | 85.34 | -76.08 | 139.52 |
Net Income to Common | 311.62 | 106.7 | 85.34 | -76.08 | 139.52 |
Net Income Growth | 195.88% | 25.03% | - | - | - |
Shares Outstanding (Basic) | 56 | 51 | 51 | 51 | 51 |
Shares Outstanding (Diluted) | 57 | 53 | 52 | 51 | 52 |
Shares Change | 8.68% | 0.71% | 2.04% | -0.70% | - |
EPS (Basic) | 5.57 | 2.08 | 1.67 | -1.49 | 2.73 |
EPS (Diluted) | 5.46 | 2.03 | 1.63 | -1.49 | 2.71 |
EPS Growth | 173.76% | 24.54% | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Free Cash Flow | 442.58 | 193.25 | 174.75 | 241.35 | -416.48 |
Free Cash Flow Per Share | 7.75 | 3.67 | 3.35 | 4.72 | -8.08 |
Dividend Per Share | 1.000 | 1.000 | - | - | - |
Dividend Growth | - | - | - | - | - |
Gross Margin | 36.57% | 33.86% | 29.65% | 23.47% | 43.61% |
Operating Margin | 13.10% | 6.88% | 4.75% | -9.45% | 14.71% |
Profit Margin | 12.81% | 6.40% | 5.22% | -7.50% | 10.20% |
Free Cash Flow Margin | 18.20% | 11.60% | 10.69% | 23.79% | -30.44% |
EBITDA | 321.99 | 119.59 | 85.08 | -87.69 | 214.87 |
EBITDA Margin | 13.24% | 7.18% | 5.20% | -8.64% | 15.71% |
D&A For EBITDA | 3.52 | 5.04 | 7.4 | 8.17 | 13.61 |
EBIT | 318.47 | 114.55 | 77.69 | -95.86 | 201.26 |
EBIT Margin | 13.10% | 6.88% | 4.75% | -9.45% | 14.71% |
Effective Tax Rate | 11.49% | 21.75% | 14.47% | - | 27.69% |